4//SEC Filing
Krivulka Joseph J 4
Accession 0001102624-13-000218
CIK 0001261734other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 6:05 PM ET
Size
7.4 KB
Accession
0001102624-13-000218
Insider Transaction Report
Form 4
Krivulka Joseph J
Director
Transactions
- Purchase
Warrants (right to buy)
2013-02-19+400,000→ 400,000 totalExercise: $0.25From: 2013-02-19Exp: 2018-02-19→ Common Stock (400,000 underlying) - Purchase
Common Stock, $0.01 par value per share
2013-02-19+400,000→ 733,333 total
Footnotes (1)
- [F1](1) Pursuant to a Securities Purchase Agreement by and between Aeolus Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Mr. Krivulka, dated as of February 19, 2013, the Company issued and sold 400,000 Units (the "Units") to Mr. Krivulka for a purchase price of $100,000. Each Unit is comprised of one (1) share of the Company's common stock, $0.01 par value per share (the "Common Stock"), and one (1) warrant to purchase one (1) share of Common Stock with an initial exercise price of $0.25 per share of Common Stock, subject to certain adjustments.
Documents
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeother
Related Parties
1- filerCIK 0001296750
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 6:05 PM ET
- Size
- 7.4 KB